About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 40159 record(s)
Req # A-2023-001523
In respect of the First Liraglutide Abbreviated New Drug Submission (ANDS), please provide the name of the company who submitted this ANDS.Organization: Health Canada
May 2024
Req # A-2023-001527
As of December 15, 2023, there are now two liraglutide submissions which appear on the Generic Submissions Under Review (GSUR) List. Provide the name of the company who submitted the Abbreviated New Drug Submission (ANDS); and the year and month in…Organization: Health Canada
May 2024
Req # A-2023-001572
Any security related training completed by Nadine Huggins, the Senior Assistant Deputy Minister (ADM) and Chief Security officer at Health Canada.Organization: Health Canada
May 2024
Req # A-2024-000099
The Public Health Agency of Canada’s (PHAC) submission or related communications that were provided to the Patented Medicine Prices Review Board (PMPRB) in response to its November 2022 Consultation on the Board’s Guidelines.Organization: Health Canada
May 2024
Req # A-2020-001326
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-112741-953.Organization: Health Canada
May 2024
Req # A-2020-001891
Adverse Drug Reactions (ADRs) for Pantoprazole sodium. Report numbers: E2B_03353411, E2B_03373956. ADRs for Tecta. Report numbers: E2B_03380105, E2B_03402109. ADRs for Pantoprazole magnesium. Report numbers: 921752, E2B_03380218. ADRs for…Organization: Health Canada
May 2024
Req # A-2021-001088
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-106818-522.Organization: Health Canada
May 2024
Req # A-2021-001202
Adverse Drug Reactions (ADRs). Report numbers: E2B_03487061, E2B_03487072, E2B_03487074, E2B_03487077, E2B_03490042, E2B_03490043, E2B_03490045, E2B_03490049, E2B_03490050, E2B_03491975, E2B_03492634, E2B_03492652, E2B_03495037, E2B_03524901,…Organization: Health Canada
May 2024
Req # A-2021-001291
Adverse Drug Reactions (ADRs). Report numbers: 000923457, E2B_03206897, 000938466, 000949183, 000956295, E2B_03838745, E2B_03998278, E2B_03081668, E2B_03840368, E2B_03940910, E2B_02771636, E2B_02836652, E2B_02836886, E2B_03503549, E2B_02758454,…Organization: Health Canada
May 2024
Req # A-2022-001617
Adverse Drug Reaction (ADR). Report number: 001025337Organization: Health Canada
May 2024